Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Wisdom of experience or faculty of reason: Ischemic mitral regurgitation trials-Cardiothoracic Surgical Trials Network and beyond.

JTCVS open·2022

Same author

Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial.

The Journal of thoracic and cardiovascular surgery·2022

Same author

Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.

Circulation·2022

Same author

Restoring ventricular restoration: A call to re-evaluate a surgical therapy considered ineffective.

Journal of cardiac surgery·2021

Same author

De Novo Renal Failure and Clinical Outcomes of Patients With Critical Coronavirus Disease 2019.

Critical care medicine·2020

Same author

The role of stem cells in treating coronary artery disease in 2018.

Indian journal of thoracic and cardiovascular surgery·2020

Same journal

Heart Failure in Adult Congenital Heart Disease.

Methodist DeBakey cardiovascular journal·2026

Same journal

The Box: A Message from the Heart in 55 Words.

Methodist DeBakey cardiovascular journal·2026

Same journal

The Initial Diagnostic Approach to Adult Congenital Heart Disease: A Practical Imaging Pathway for General Cardiologists and Cardiac Imagers.

Methodist DeBakey cardiovascular journal·2026

Same journal

Unrepaired Congenital Shunt Lesions in Adults: Principles for Clinical Management.

Methodist DeBakey cardiovascular journal·2026

Same journal

Adult Congenital Heart Disease at the Crossroads of Innovation.

Methodist DeBakey cardiovascular journal·2026

Same journal

Transcatheter Edge-to-Edge Repair in Adult Congenital Heart Disease: Anatomic Challenges, Device Adaptations, and Emerging Evidence.

Methodist DeBakey cardiovascular journal·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Stem cell therapy for heart failure.

Robert E Michler¹

¹Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York.

Methodist Debakey Cardiovascular Journal

|December 4, 2013

Summary

This summary is machine-generated.

First-generation stem cell therapy using bone marrow cells is safe and modestly effective. Current research suggests paracrine effects, not cell transdifferentiation, drive these benefits, shifting focus to cardiac lineage stem cells.

Keywords:

heart failure regenerative medicine stem cell therapy

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 5, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Area of Science:

Regenerative Medicine
Cardiovascular Research
Stem Cell Biology

Background:

Recent clinical trials have primarily utilized bone marrow-derived stem cells.
These trials have established the safety and modest efficacy of cell therapy.
Key findings indicate a lack of significant transdifferentiation into cardiomyocytes or new blood vessels.

Purpose of the Study:

To review the outcomes of first-generation stem cell clinical trials.
To elucidate the primary mechanisms of action for cell therapy in cardiac applications.
To identify future directions for stem cell therapy in cardiovascular regeneration.

Main Methods:

Analysis of published clinical trial data from the past decade.
Evaluation of cellular mechanisms, including transdifferentiation and paracrine signaling.
Review of current research trends in stem cell therapy.

Main Results:

Cell therapy is confirmed as safe with modest effectiveness.
Bone marrow-derived stem cells do not significantly transdifferentiate in humans.
The primary therapeutic effect is mediated by paracrine factors.

Conclusions:

Cell therapy's benefits stem from paracrine effects, including anti-apoptotic and anti-fibrotic signaling.
These effects enhance cardiac contractility and activate endogenous repair mechanisms.
Future trials should explore stem cells with inherent cardiac lineage potential, such as endogenous cardiac stem cells.